Viva Biotech Holdings, an investment holding company, provides structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide. The company provides EFS, gene-to-protein and gene-to-structure, medicinal chemistry, in vitro pharmacology, membrane protein targeted drug discovery, and antibody discovery services, as well as Viva Engine, a platform for lead discovery. It also offers cell lines, crystal structures, GPCR proteins, antibodies, and proteins.

In addition, the company provides contract development and manufacturing services for small molecule active pharmaceutical ingredients (APIs) and intermediates; and trades in APIs, intermediates, and formulations. Viva Biotech has a strategic collaboration agreement with BioMap Reach to jointly develop the early drug discovery through AI technology. Viva Biotech Holdings was incorporated in 2008 and is headquartered in Shanghai, China.